Oct. 12 marked one year since the U.S. Food and Drug Administration’s formal announcement that pharmaceutical companies were unable to produce enough Adderall, one of the common amphetamine-based medications for attention-deficit/hyperactivity disorder (ADHD).
One Year Later, Where’s All the Adderall?
ellisjohn October 20, 2023Books
drug administration
https://time.com/6324717/one-year-later-wheres-all-the-adderall/